Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Cholecystectomy is Feasible in Children with Small-Sized or Large Numbers of Gallstones and in Those with Persistent Symptoms Despite Medical Treatment

  • Lee, Yeoun Joo (Department of Pediatrics, Pusan National University School of Medicine) ;
  • Park, Yeh Seul (Department of Pediatrics, Pusan National University School of Medicine) ;
  • Park, Jae Hong (Department of Pediatrics, Pusan National University School of Medicine)
  • Received : 2020.03.10
  • Accepted : 2020.05.01
  • Published : 2020.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: We investigated the clinical features and factors affecting the choice of treatment modality and the course of pediatric gallstone (GS) disease. Methods: We retrospectively analyzed the medical records of 65 patients diagnosed with GS using imaging studies between January 2009 and December 2017 were included. Results: This study included 65 patients (33 boys and 32 girls; mean age, 8.5±5.3 years; range, 0.2-18 years) who primarily presented with abdominal pain (34%), jaundice (18%), and vomiting (8%). Idiopathic GS occurred in 36 patients (55.4%). The risk factors for GS included antibiotic use, obesity, hemolytic disease, and chemotherapy in 8 (12.3%), 7 (10.8%), 6 (9.2%), and 4 patients (6.2%), respectively. We observed multiple stones (including sandy stones) in 31 patients (47.7%), a single stone in 17 (26.2%), and several stones in 17 (26.2%). GS with a diameter of <5 mm occurred in 45 patients (69.2%). Comorbidities included hepatitis, choledocholithiasis, cholecystitis, and acute pancreatitis in 20 (30.8%), 11 (16.9%), 11 (16.9%), and 4 patients (6.2%), respectively. Ursodeoxycholic acid (UDCA) was administered to 54 patients (83.1%), leading to stone dissolution in 22 patients (33.8%) within 6 months. Cholecystectomy was performed in 18 patients (27.7%) (mean age, 11.9±5.1 years). Most patients treated surgically had multiple stones (83%) and stones measuring <5 mm in size (89%), and 66.7% of patients had cholesterol stones. Conclusion: Cholecystectomy is feasible in patients with small-sized or large numbers of GS and those with persistent abdominal pain and/or jaundice. UDCA administration with close follow-up is recommended in patients with uncomplicated GS.

Keywords

References

  1. Palasciano G, Portincasa P, Vinciguerra V, Velardi A, Tardi S, Baldassarre G, et al. Gallstone prevalence and gallbladder volume in children and adolescents: an epidemiological ultrasonographic survey and relationship to body mass index. Am J Gastroenterol 1989;84:1378-82.
  2. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Ikematsu H, Noguchi A, et al. Prevalence of gallstone disease in a general population of Okinawa, Japan. Am J Epidemiol 1988;128:598-605. https://doi.org/10.1093/oxfordjournals.aje.a115007
  3. Wesdorp I, Bosman D, de Graaff A, Aronson D, van der Blij F, Taminiau J. Clinical presentations and predisposing factors of cholelithiasis and sludge in children. J Pediatr Gastroenterol Nutr 2000;31:411-7. https://doi.org/10.1097/00005176-200010000-00015
  4. Herzog D, Bouchard G. High rate of complicated idiopathic gallstone disease in pediatric patients of a North American tertiary care center. World J Gastroenterol 2008;14:1544-8. https://doi.org/10.3748/wjg.14.1544
  5. Mehta S, Lopez ME, Chumpitazi BP, Mazziotti MV, Brandt ML, Fishman DS. Clinical characteristics and risk factors for symptomatic pediatric gallbladder disease. Pediatrics 2012;129:e82-8. https://doi.org/10.1542/peds.2011-0579
  6. Di Ciaula A, Wang DQ, Wang HH, Bonfrate L, Portincasa P. Targets for current pharmacologic therapy in cholesterol gallstone disease. Gastroenterol Clin North Am 2010;39:245-64, viii-ix. https://doi.org/10.1016/j.gtc.2010.02.005
  7. Kaechele V, Wabitsch M, Thiere D, Kessler AL, Haenle MM, Mayer H, et al. Prevalence of gallbladder stone disease in obese children and adolescents: influence of the degree of obesity, sex, and pubertal development. J Pediatr Gastroenterol Nutr 2006;42:66-70. https://doi.org/10.1097/01.mpg.0000187816.31213.06
  8. Waldhausen JH, Benjamin DR. Cholecystectomy is becoming an increasingly common operation in children. Am J Surg 1999;177:364-7. https://doi.org/10.1016/S0002-9610(99)00063-X
  9. Miltenburg DM, Schaffer R 3rd, Breslin T, Brandt ML. Changing indications for pediatric cholecystectomy. Pediatrics 2000;105:1250-3. https://doi.org/10.1542/peds.105.6.1250
  10. Balaguer EJ, Price MR, Burd RS. National trends in the utilization of cholecystectomy in children. J Surg Res 2006;134:68-73. https://doi.org/10.1016/j.jss.2006.02.053
  11. Bogue CO, Murphy AJ, Gerstle JT, Moineddin R, Daneman A. Risk factors, complications, and outcomes of gallstones in children: a single-center review. J Pediatr Gastroenterol Nutr 2010;50:303-8. https://doi.org/10.1097/MPG.0b013e3181b99c72
  12. Stringer MD. Gallbladder disease and cholelithiasis. In: Howard ER, Stringer MD, Colombani PM, eds. Surgery of the liver, bile ducts and pancreas in children. 2nd ed. London: Arnold Publishers, 2002:189-208.
  13. Serdaroglu F, Koca YS, Saltik F, Koca T, Dereci S, Akcam M, et al. Gallstones in childhood: etiology, clinical features, and prognosis. Eur J Gastroenterol Hepatol 2016;28:1468-72. https://doi.org/10.1097/MEG.0000000000000726
  14. Friesen CA, Roberts CC. Cholelithiasis. Clinical characteristics in children. Case analysis and literature review. Clin Pediatr (Phila) 1989;28:294-8. https://doi.org/10.1177/000992288902800701
  15. Svensson J, Makin E. Gallstone disease in children. Semin Pediatr Surg 2012;21:255-65. https://doi.org/10.1053/j.sempedsurg.2012.05.008
  16. Chang YR, Jang JY, Kwon W, Park JW, Kang MJ, Ryu JK, et al. Changes in demographic features of gallstone disease: 30 years of surgically treated patients. Gut Liver 2013;7:719-24. https://doi.org/10.5009/gnl.2013.7.6.719
  17. Jeong SU, Lee SK. Obesity and gallbladder diseases. Korean J Gastroenterol 2012;59:27-34. https://doi.org/10.4166/kjg.2012.59.1.27
  18. Gracie WA, Ransohoff DF. The natural history of silent gallstones: the innocent gallstone is not a myth. N Engl J Med 1982;307:798-800. https://doi.org/10.1056/NEJM198209233071305
  19. Della Corte C, Falchetti D, Nebbia G, Calacoci M, Pastore M, Francavilla R, et al. Management of cholelithiasis in Italian children: a national multicenter study. World J Gastroenterol 2008;14:1383-8. https://doi.org/10.3748/wjg.14.1383
  20. Tannuri AC, Leal AJ, Velhote MC, Gonlcalves ME, Tannuri U. Management of gallstone disease in children: a new protocol based on the experience of a single center. J Pediatr Surg 2012;47:2033-8. https://doi.org/10.1016/j.jpedsurg.2012.06.010
  21. Venneman NG, Buskens E, Besselink MG, Stads S, Go PM, Bosscha K, et al. Small gallstones are associated with increased risk of acute pancreatitis: potential benefits of prophylactic cholecystectomy? Am J Gastroenterol 2005;100:2540-50. https://doi.org/10.1111/j.1572-0241.2005.00317.x
  22. Guarino MP, Cocca S, Altomare A, Emerenziani S, Cicala M. Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed. World J Gastroenterol 2013;19:5029-34. https://doi.org/10.3748/wjg.v19.i31.5029
  23. Roma MG, Toledo FD, Boaglio AC, Basiglio CL, Crocenzi FA, Sanchez Pozzi EJ. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications. Clin Sci (Lond) 2011;121:523-44. https://doi.org/10.1042/CS20110184
  24. Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. J Hepatol 2001;35:134-46. https://doi.org/10.1016/S0168-8278(01)00092-7
  25. Villanova N, Bazzoli F, Taroni F, Frabboni R, Mazzella G, Festi D, et al. Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment. Gastroenterology 1989;97:726-31. https://doi.org/10.1016/0016-5085(89)90644-6
  26. Portincasa P, Ciaula AD, Bonfrate L, Wang DQ. Therapy of gallstone disease: what it was, what it is, what it will be. World J Gastrointest Pharmacol Ther 2012;3:7-20. https://doi.org/10.4292/wjgpt.v3.i2.7
  27. Tomida S, Abei M, Yamaguchi T, Matsuzaki Y, Shoda J, Tanaka N, et al. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis. Hepatology 1999;30:6-13. https://doi.org/10.1002/hep.510300108
  28. Venneman NG, Besselink MG, Keulemans YC, Vanberge-Henegouwen GP, Boermeester MA, Broeders IA, et al. Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy. Hepatology 2006;43:1276-83. https://doi.org/10.1002/hep.21182
  29. Khoo AK, Cartwright R, Berry S, Davenport M. Cholecystectomy in English children: evidence of an epidemic (1997-2012). J Pediatr Surg 2014;49:284-8, discussion 288. https://doi.org/10.1016/j.jpedsurg.2013.11.053
  30. National Institutes of Health consensus development conference statement on gallstones and laparoscopic cholecystectomy. Am J Surg 1993;165:390-8. https://doi.org/10.1016/S0002-9610(05)80929-8
  31. Scientific Committee of the European Association for Endoscopic Surgery (E.A.E.S.). Diagnosis and treatment of common bile duct stones (CBDS). Results of a consensus development conference. Surg Endosc 1998;12:856-64. https://doi.org/10.1007/s004649900729
  32. Huguier M, Bornet P, Charpak Y, Houry S, Chastang C. Selective contraindications based on multivariate analysis for operative cholangiography in biliary lithiasis. Surg Gynecol Obstet 1991;172:470-4.
  33. Taylor TV, Armstrong CP, Rimmer S, Lucas SB, Jeacock J, Gunn AA. Prediction of choledocholithiasis using a pocket microcomputer. Br J Surg 1988;75:138-40. https://doi.org/10.1002/bjs.1800750216
  34. Costi R, Sarli L, Caruso G, Iusco D, Gobbi S, Violi V, et al. Preoperative ultrasonographic assessment of the number and size of gallbladder stones: is it a useful predictor of asymptomatic choledochal lithiasis? J Ultrasound Med 2002;21:971-6. https://doi.org/10.7863/jum.2002.21.9.971

Cited by

  1. Biliary sludge: pathogenesis, etiology and drug therapy vol.93, pp.2, 2020, https://doi.org/10.26442/00403660.2021.02.200638